Researcher.Life Logo

European Journal of Medicinal Chemistry : Impact Factor & More

eISSN: 1768-3254pISSN: 0223-5234

Aims and Scope of European Journal of Medicinal Chemistry

The European Journal of Medicinal Chemistry is a monthly peer-reviewed scientific journal covering medicinal chemistry and published by Elsevier. It was established in 1966 as Chimica Therapeutica (CODEN: CHTPBA) and obtained its current title in 1974. From 1974 to 1981 the journal was still subtitled as Chimica Therapeutica and from 1982 to 1986 the subtitle was Chimie Thérapeutique, indicating its French origin. And now it is the journal of the French Société de Chimie Thérapeutique. Less

Key Metrics

CiteScore
11.2
H-Index
188
Impact Factor
5 - 10
Scite Index
0.93 5-Year SI
SJR
Q1Pharmacology
SNIP
1.57
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on European Journal of Medicinal Chemistry

European Journal of Medicinal Chemistry Journal Specifications

Overview
Publisher ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
Language Multi-Language
Frequency Semi-monthly
General Details
LanguageMulti-Language
FrequencySemi-monthly
Publication Start Year1965
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in European Journal of Medicinal Chemistry ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in European Journal of Medicinal Chemistry

New mechanistic insights into targeted protein degradation using Raman-active theranostic hydrophobic tags.
  • 5 Feb 2026
  • European journal of medicinal chemistry
Corrigendum to 'Novel ligustilide derivatives target quorum sensing system LasR/LasB and relieve inflammatory response against Pseudomonas aeruginosa infection' [Eur J Med Chem. 263 (2024) 115972
  • 5 Feb 2026
  • European journal of medicinal chemistry
Identification of N-tert-butyloxycarbonyl protected amino acids as novel hydrophobic tags to induce targeted protein degradation.
  • 5 Feb 2026
  • European journal of medicinal chemistry
Design of conditional and tumor-activated PROTACs for selective degradation in lung cancer.
  • 5 Feb 2026
  • European journal of medicinal chemistry
Direct small-molecule inhibitors of the Keap1-Nrf2 protein-protein interaction: Scaffold evolution, PROTAC strategies, and therapeutic implications.
  • 5 Feb 2026
  • European journal of medicinal chemistry
Design, synthesis, and biological evaluation of novel PROTACs based on unnatural dipeptide CRBN ligands.
  • 1 Feb 2026
  • European journal of medicinal chemistry
New mechanistic insights into targeted protein degradation using Raman-active theranostic hydrophobic tags.
  • 5 Feb 2026
  • European journal of medicinal chemistry
Corrigendum to 'Novel ligustilide derivatives target quorum sensing system LasR/LasB and relieve inflammatory response against Pseudomonas aeruginosa infection' [Eur J Med Chem. 263 (2024) 115972
  • 5 Feb 2026
  • European journal of medicinal chemistry
Identification of N-tert-butyloxycarbonyl protected amino acids as novel hydrophobic tags to induce targeted protein degradation.
  • 5 Feb 2026
  • European journal of medicinal chemistry
Design of conditional and tumor-activated PROTACs for selective degradation in lung cancer.
  • 5 Feb 2026
  • European journal of medicinal chemistry
Direct small-molecule inhibitors of the Keap1-Nrf2 protein-protein interaction: Scaffold evolution, PROTAC strategies, and therapeutic implications.
  • 5 Feb 2026
  • European journal of medicinal chemistry
Design, synthesis, and biological evaluation of novel PROTACs based on unnatural dipeptide CRBN ligands.
  • 1 Feb 2026
  • European journal of medicinal chemistry

FAQs on European Journal of Medicinal Chemistry